news Engel steps up Chinese activities
Austrian machinery maker Engel is stepping up its activities in China with the creation of a new wholly-owned subsidiary – WINTEC – that will manufacture and sell standard- ised machines aimed at the mainstream Chinese injection moulding sector. The new WINTEC factory is being built at Changzhou around 120 miles north-west of Shanghai, where Engel already has a manufacturing operation for large two platen machines, and will begin production in the summer. It will have its own sales and service capabilities and will operate completely indepen- dently of Engel in China.
Architect’s impression of the WINTEC plant in China
“This strategic decision
allows us to open up a new target group for Engel and strengthen our foothold in Asia at the same time,” said Engel CEO Dr Peter Neumann. “Our goal for WINTEC is to appeal to processors looking for relatively standardised machines with a limited range of options.”
Engel, which generated
global sales of €950m for the last financial year, has had considerable success in Asia. The region now accounts for 18% (€145m) of its sales, half of which comes from China. However, the company’s success has been in the high technology sectors, where it
competes with other European and Japanese machine builders.
WINTEC will be competing in the much larger market for commodity machines, where it will be up against Chinese, Taiwanese and Korean firms. Last year, Neumann told Injection World he estimated commodity machine sales in China to amount to around 14,200 units a year, compared to just 1,000 high technology units. The WINTEC operation will be headed up by Peter Auinger, who has moved to take on the role of CEO from Engel Mexico. “The requirements of Asian commodity manufacturers for energy efficiency, precision as
well as supplier services have increased sharply over the past years. Local suppliers, however, do not sufficiently meet these requirements.” he said. While the new business will
operate separately from Engel’s other operations, it will be integrated into the com- pany’s global quality manage- ment system. The key difference between the product lines will be in WINTEC’s more standardised designs. This will allow the company to offer more competitive pricing and shorter delivery lead-times. “There is hardly any overlap with the series of Engel,” said Auinger. “Until now, commodity manufacturers in Asia have mainly used injection moulding machines from Taiwanese, Korean, and Chinese suppliers. With WINTEC we are develop- ing new target markets.” Engel already manufactures
high technology injection moulding equipment in Asia. It builds tiebar-less machines at a plant at Pynugtaek City in Korea and larger Duo two- platen machines at Shanghai. ❙
www.engelglobal.com
Nolato posts record 2013 result
Swedish technical moulding group Nolato reported its best ever results for 2013 with sales up by 17% to reach SEK4,522m (€498m), boosted by strong contributions from its medical and telecoms divisions. Sales in the medical division
were up by 10% on the previous year to SEK1,274m (€140m), telecom sales were up by 34% to SEK2,079m (€229m).
www.injectionworld.com
Industrial was unchanged at SEK1,170m (€129m). “In recent years we have
focused on creating a balanced group structure with three business areas, which we have achieved along with continu- ous enhancement of our profit- ability. Amongst other things, this strategic direction has led to a series of successful acquisitions at Nolato Medical,
which is currently responsible for around 30% of group turnover,” said Nolato’s President and CEO Hans Porat. Porat said he was disap-
pointed that the company had not met its acquisition goals in full during the year. However, he said that the company was continuing to explore further opportunities. ❙
www.nolato.com
Exploring further acquisitions: Nolato CEO Hans Porat
April 2014 | INJECTION WORLD 5
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76